خرید ایبوک Clinical Reasoning and Decision-Making in Psychiatry

برای دانلود ایبوک Clinical Reasoning and Decision-Making in Psychiatry و خرید کتاب استدلال بالینی و تصمیم گیری در روانپزشکی بر روی کلید خرید در انتهای صفحه کلیک کنید. پس از اتصال به درگاه پرداخت هزینه و تکمیل مراحل خرید، لینک دانلود کتاب ایمیل می شود.این ایبوک در فرمت PDF اورجینال کلیه فصول و به زبان انگلیسی ارسال می شود.نسخه الکترونیکی کتاب قابلیت کپی برداری copy و Paste دارد.

در صورتی که نیاز به پی دی اف هر کتابی از انتشارات cambridge دارید با گیگاپیپر مکاتبه کنید.

خرید کتاب Clinical Reasoning and Decision-Making in Psychiatry

Clinical Reasoning and Decision-Making in Psychiatry

Joseph F. Goldberg, Icahn School of Medicine at Mount Sinai, New York,Stephen M. Stahl, University of California San Diego

Publisher: Cambridge University Press

Online publication date: March 2024

Print publication year: 2024

Online ISBN: 9781009181549

DOI: https://doi.org/10.1017/9781009181549

ISBN-10 ‏ : 1009181556

ISBN-13 ‏ : ‎ 978-1009181556

Send email to download :

Price : 25$

https://www.cambridge.org/core/books/clinical-reasoning-and-decisionmaking-in-psychiatry/461AFF39C01B086C943AD489FDCFDAF9

https://www.amazon.com/Clinical-Reasoning-Decision-Making-Psychiatry-Goldberg/dp/1009181556

دانلود رایگان کتاب Clinical Reasoning and Decision-Making in Psychiatry

Mental health professionals routinely make treatment decisions without necessarily having an overarching perspective about optimal next steps. This important new book provides them with reader-friendly, pragmatic strategies to approach clinical problems as testable hypotheses. It discusses how to apply concepts based on decision analytic theory using risk-benefit analyses, contingency planning, measurement-based care, shared decision making, pharmacogenetics, disease staging, and machine learning. Readers will learn how these tools can help them craft optimal pharmacological and psychosocial interventions tailored to the needs of an individual patient. The book covers topics such as diagnostic ambiguity, interview technique, applying statistical concepts to individual patients, artificial intelligence, and managing high-risk, treatment-resistant, or demanding and difficult patients. Valuable clinical vignettes are featured throughout the book to illustrate common dilemmas and scenarios where the relative merits of competing treatment options invite a more iterative than definitive approach. For all healthcare professionals who prescribe psychotropic medications.

دانلود ایبوک استدلال بالینی و تصمیم گیری در روانپزشکی

متخصصان سلامت روان به طور معمول تصمیمات درمانی را بدون داشتن دیدگاهی فراگیر در مورد مراحل بعدی بهینه می گیرند. این کتاب جدید و مهم، راهبردهای عمل‌گرایانه و خواننده پسند را در اختیار آنها قرار می‌دهد تا به مشکلات بالینی به عنوان فرضیه‌های قابل آزمایش نزدیک شوند. این مقاله نحوه به کارگیری مفاهیم مبتنی بر تئوری تجزیه و تحلیل تصمیم را با استفاده از تجزیه و تحلیل ریسک-منافع، برنامه ریزی احتمالی، مراقبت مبتنی بر اندازه گیری، تصمیم گیری مشترک، فارماکوژنتیک، مرحله بندی بیماری و یادگیری ماشین مورد بحث قرار می دهد. خوانندگان یاد خواهند گرفت که چگونه این ابزارها می توانند به آنها در ایجاد مداخلات دارویی و روانی اجتماعی بهینه متناسب با نیازهای هر بیمار کمک کنند. این کتاب موضوعاتی مانند ابهام تشخیصی، تکنیک مصاحبه، به کارگیری مفاهیم آماری برای بیماران فردی، هوش مصنوعی، و مدیریت بیماران پرخطر، مقاوم به درمان یا سخت‌گیرانه را پوشش می‌دهد. طرح‌های بالینی ارزشمند در سراسر کتاب برای نشان دادن معضلات و سناریوهای رایج که در آن شایستگی‌های نسبی گزینه‌های درمانی رقیب، رویکردی تکراری‌تر از قطعی را دعوت می‌کنند، نشان داده شده‌اند. برای تمام متخصصان مراقبت های بهداشتی که داروهای روانگردان تجویز می کنند.

فهرست مطالب Clinical Reasoning and Decision Making in Psychiatry

1. Cover
2. Half title
3. Reviews
4. Title page
5. Imprints page
6. Contents
7. Foreword
8. Preface
9. 1 Making Sense of the Senseless: How to Gather and Organize Pertinent Information
10. A It’s All About the Narrative
11. B Organizing a Coherent History: Start from the Beginning
12. C Are Diagnostic Criteria Met?
13. D Are DSM Criteria Written Mainly for Clinicians or Researchers?
14. E Hierarchical Diagnostic Treatment Approaches: How to Triage
15. F Signs and Symptoms
16. G Depression as a Disorder of Information Processing
17. H Interface Symptoms: When Delusions Meet Obsessions
18. I The Longitudinal Stability of Psychiatric Diagnoses
19. J Understanding Attachment Styles as a Clue to Diagnostic Formulations
20. K Information Flow
21. L Those Who Do Not Learn from the Pharmacological Past Are Doomed to Repeat It
22. M The Art of Interpreting Gathered Clinical Information
23. References
24. 2 The Approach to Diagnostic Ambiguity
25. A What to Do if You Don’t Know What You’re Treating
26. B Symptomatic Overlap
27. C Substance Use as a Diagnostic Confounder
28. D Corroborators of a Psychiatric Diagnosis
29. D.1 Expected Epidemiology
30. D.2 Family History
31. D.3 Laboratory Measures
32. D.4 Treatment Response
33. D.5 Longitudinal Course
34. E Strengths and Limitations of Diagnostic Screens
35. F Working with Diagnostic Ambiguity: The Role for Hypothesis-Testing and Pharmacotherapy as a Diagnostic Assay
36. G Inpatient Admission for Diagnostic Assessment and “Acute Stabilization”
37. H When Ordering Psychological Testing May Be Helpful
38. I Lingering Symptoms
39. References
40. 3 What the Patient Isn’t Telling You: When Seeing Is Not Believing
41. A You Should Believe Everything Patients Tell You – Right?
42. B Collateral Input from Family Members is Usually Accurate – Right?
43. C Family History/Genetic Information is Usually Accurate – Right?
44. D Substance Use Sleuthing
45. E Anosognosia
46. F Alexithymia
47. G Psychosis
48. H Lying About Suicide
49. I Decision-Making for Patients with Poor Distress Tolerance
50. J Paradoxical Drug Reactions and the Nocebo Phenomenon
51. K Blips versus Trends
52. L Motivational Interviewing
53. M Paradoxical Injunctions
54. References
55. 4 Shared Decision-Making
56. A Why Shared Decision-Making?
57. B Basic Tenets of Shared Decision-Making
58. C The Impact of Shared Decision-Making on Clinical Outcomes
59. D Collaborative Decision-Making in Iterative Psychopharmacology: Identifying Patient Preferences
60. E Defining Patient and Practitioner Goals
61. F Shared Risk-Taking
62. G Capacity to Make an Informed Decision
63. H When Patients Make Faulty Inferences
64. I Inappropriate Requests
65. J When Clinicians Make Faulty Inferences
66. K Ultimatums
67. L Anger and Hostility
68. M Shared Decision-Making as Motivational Interviewing
69. N Psychosis
70. O Treatment Over Objection
71. P Information Sharing: Translating from the Bench to the Bedside
72. Q Now That I’m Well Can I Stop My Treatment?
73. R When Deception and Manipulation Serve a Therapeutic Function
74. S Shared Decision-Making When One Party Has an Agenda
75. T When Patients Just Want to Be Told What to Do
76. References
77. 5 Deciding on Appropriate Treatment Modalities: Medication, Psychotherapy, Hospitalization, and Other Levels of Care
78. A Disease-Modifying versus Disease-Managing Treatments
79. B Situational Situations and Recognizing a Diathesis
80. C When Is Pharmacotherapy Indicated?
81. D Are All Mental Health Conditions Pharmacologically Responsive?
82. E When Is Psychotherapy Indicated?
83. F When Should Psychotherapy Be Considered as an Augmentation to Pharmacotherapy?
84. G Psychodynamically Informed Pharmacotherapy
85. H Psychotherapy as a Preferred Intervention When Medications Prove Unhelpful
86. I Decision-Making in the Setting of Shaky Treatment Adherence
87. J Managing Chronic versus Acute Suicidal Ideation
88. K The Need for a Higher Level of Care
89. L Alternatives to Hospitalization
90. M It Takes a Village
91. N Treatment Endpoints and the Art of Deprescribing
92. O Deprescribing After Lack of Efficacy
93. P When No Treatment is the Treatment of Choice
94. References
95. 6 Measurement-Based Care and Applying Statistical Concepts to the Individual Patient
96. A Do Rating Scales Improve Clinical Outcomes?
97. B What to Measure?
98. C Psychometric Validation of Rating Scales
99. D Diagnostic Screens
100. E Rating Scales Related to Depression
101. F Psychosocial Functioning
102. G Measuring Adverse Drug Effects
103. H Disease Staging
104. I Translating Statistical Concepts to Clinical Care Decisions
105. J The Role of Machine Learning for Measurement-Based Care
106. References
107. 7 Hypothesis-Testing and Crafting Patient-Specific Decision Trees
108. A Everything Is a Testable Hypothesis
109. B Pattern Recognition
110. C Apophenic Psychopharmacology
111. D Hypothesis Generation and Testing
112. E Hypothesis Generation versus Testing
113. F What is Expectancy Bias and How Does It Influence Assessment and Decision-Making?
114. G When Anecdotal Observations Inspire Hypothesis Formulation
115. H Probable versus Improbable Consequences
116. I Hypothesis Framing: Ask Tangibly Answerable Yes/No Questions
117. J Biases About Medication Dose–Response Relationships
118. K Teaching Patients How to Formulate and Test Their Own Hypotheses
119. L Crafting Patient-Specific Decision Trees
120. L.1 Patient-Tailored Decision Trees
121. M Using the Literature
122. References
123. 8 Decision Points in Iterative Pharmacotherapy
124. A Choosing from Among Appropriate Agents
125. B Adopting an Iterative Clinical Mindset: Becoming a Pharmacological Chessmaster
126. C Limitations of Treatment Algorithms and Practice Guidelines
127. D Iterative Pharmacotherapy in Major Depression
128. E Outliers and Blips
129. F Articulating the Pros and Cons of One Treatment versus Another
130. F.1 Thinking It Through
131. F.2 Constructing a Decision-Analytic Matrix
132. G Best–Worst Scaling
133. H Iterative Pharmacotherapy in Psychotic Disorders
134. I Knowing Which One Variable at a Time to Change First
135. I.1 Clinical Reasoning
136. J Back-Up Plans and Back Ups to the Back-Up Plans
137. K How Is the Clinician’s Own Working Memory?
138. L How Does Therapeutic Drug Monitoring or Pharmacogenetics Fit into Iterative Pharmacotherapy?
139. M Recognizing Pharmacological Futility and Alternatives to Pharmacotherapy
140. References
141. 9 Hierarchical and Complex Pharmacotherapy Decision-Making
142. A Taking a Hierarchical Triage Approach to Iterative Therapeutics
143. B Broadening the Spectrum of Pharmacological Mechanisms of Action
144. C The Rules of Medication Switches and Cross-Tapers
145. D Nonresponse to an SSRI for Depression: Now What?
146. E Risky Business: Aggressive Drug Combinations for Hard-to-Treat Conditions
147. F More on the Pros and Cons of Risk–Benefit Analyses
148. G Symptom Clusters: Can They, and Should They, Guide Medication Decisions?
149. H Refractory OCD
150. I Stimulant Tolerance During Treatment for ADHD
151. J Bad, Bad, Bad Insomnia
152. K Laboratory Tools to Inform Pharmacotherapy Decisions: The Role of Pharmacogenetics
153. L Fun with SNPs
154. M (More on) Therapeutic Drug Monitoring as a Decisional Tool
155. N The Art of Deprescribing
156. O Pharmacological Jenga®
157. References
158. 10 Prioritizing the Components of Any Decision-Making Model
159. A The Single Most Important Factor in Clinical Decision-Making
160. B The Second Most Important Factor in Clinical Decision-Making
161. C Criteria and Indications for Specific Psychotherapies
162. D Using the Right Tool for the Right Job
163. E A Word on The Impact of Third-Party Constraints in the Decision-Making Process
164. F Differentiating On- or Off-Label versus Evidence-Based Pharmacotherapies
165. G Ain’t Broke Don’t Fix
166. H Hold That Pose
167. I On–Off–On Designs
168. J When and How to Summon Your Inner Statistician
169. J.1 Goodness of Fit
170. J.2 Interaction Effects
171. K Treatment Endpoints Revisited
172. L The Palliative Model When Facing Pharmacological Futility
173. References
174. Index